{
    "id": "51429830",
    "text": "Acoziborole (SCYX-7158) is an antiprotozoal drug invented by Anacor Pharmaceuticals in 2009, and now under development by the Drugs for Neglected Diseases Initiative for the treatment of African trypanosomiasis (Sleepisg sickness). It is a structurally novel drug described as a benzoxaborole derivative, and is a one-day, one-dose oral treatment. Phase I human clinical trials were completed successfully in 2015, and it is now in Phase IIb/III trials being carried out in the Democratic Republic of the Congo, where most cases of sleeping sickness occur. == See also == * Tavaborole == References == Category:Trifluoromethyl compounds Category:Organoboron compounds Category:Fluoroarenes ",
    "title": "SCYX-7158"
}